Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A preliminary attempt to personalize risperidone dosing using drug-drug interactions and genetics: part I.

Psychosomatics - 1 Jan 2000

de Leon Jose, Sandson Neil B, Cozza Kelly L

Abstract excerpt

BACKGROUND: Personalized prescription is described even in lay journals, but there has been no attempt to propose personalizing dosing for any specific psychiatric drug. OBJECTIVE: Any attempt to develop personalized dosing needs to be anchored in our understanding of the pharmacological response...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Cytochrome P-450 CYP2D6
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Interactions

Share to Receptors, Adrenergic

Share to Receptors, Dopamine D2

Share to Receptors, Serotonin

Share to Risperidone

Source

Identifiers

PMID: 18448784
DOI: 10.1176/appi.psy.49.3.258

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18448784-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A preliminary attempt to personalize risperidone dosing using drug-drug interactions and genetics: part I.PMID 18448784Read ↗

Pharmacogenetics of Clinical Response to RisperioneSemantic proximity Read ↗

Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.Semantic proximity Read ↗

Using pharmacokinetics and pharmacogenetics to optimize psychiatric treatments: A systematic review.Semantic proximity Read ↗

Risperidone plasma levels, clinical response and side-effects.Semantic proximity Read ↗

Identification of genetic correlates of response to Risperidone: Findings of a multicentric schizophrenia study from India.Semantic proximity Read ↗

Comparing the influence of dopamine D₂ polymorphisms and plasma drug concentrations on the clinical response to risperidone.Semantic proximity Read ↗

Intuitive pharmacogenetics: spontaneous risperidone dosage is related to CYP2D6, CYP3A5 and ABCB1 genotypes.Semantic proximity Read ↗

Pharmacogenetics of psychotropic drug response.Semantic proximity Read ↗

[Pharmacogenetics in Parkinson's disease treatment].Semantic proximity Read ↗

Relevance of CYP2D6 variability in first-episode schizophrenia patients treated with risperidone.Semantic proximity Read ↗

Genetic and environmental factors affecting drug response in man.Semantic proximity Read ↗

ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.